Hospitalizations because of chicken pox down dramatically since implementation of vaccineAugust 17, 2005Since the introduction of the varicella (chicken pox) vaccine in 1995, hospitalizations and doctor visits because of chicken pox have dropped dramatically, according to a study in the August 17 issue of JAMA. Varicella vaccine is recommended for routine immunization of children aged 12 to 18 months and for older susceptible children and adults in the United States, according to background information in the article. Before its licensure in 1995, almost everyone developed chicken pox; thus, incidence approximated the birth cohort, with about 13,000 hospitalizations and 100 to 150 deaths annually. Varicella vaccine coverage has increased steadily, reaching 81 percent in 2002 among children aged 19 to 35 months nationally, while varicella disease incidence has declined in all age groups. However, data documenting the impact of vaccination on varicella-related health care utilization have previously been limited. Fangjun Zhou, Ph.D., M.S., of the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, and colleagues conducted a study to determine the patterns of hospitalization and ambulatory visits for chicken pox and their associated medical expenditures in the United States, evaluating these factors beginning in 1994 (before availability of varicella vaccine) through 2002 (7 years after vaccine licensure). Data included enrollees (children and adults) of more than 100 health insurance plans of approximately 40 large U.S. employers.
The researchers found that from the prevaccination period to 2002, hospitalizations due to chicken pox declined by 88 percent (from 2.3 to 0.3 per 100,000 population) and ambulatory visits declined by 59 percent (from 215 to 89 per 100,000 population). Hospitalizations and ambulatory visits declined in all age groups, with the greatest declines among infants younger than 1 year. Total estimated direct medical expenditures for chicken pox hospitalizations and ambulatory visits declined by 74 percent, from an average of $84.9 million in 1994 and 1995 to $22.1 million in 2002. "The data in our study demonstrate the substantial success that the varicella vaccine program has shown since it was implemented 10 years ago. However, nationally representative data are needed to more accurately monitor the impact of the varicella vaccination program. The Council of State and Territorial Epidemiologists has recommended that states now begin to conduct case-based surveillance," the authors conclude. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Chicken Pox Current Events and Chicken Pox News Articles Study finds fears of HIV transmission in families with infected parent Despite ongoing efforts to educate the public about HIV, a new study by researchers from UCLA, the RAND Corp., Harvard University and Children's Hospital Boston has found that two-thirds of families with an HIV-infected parent experience fears about spreading HIV in the home. Research leading to tools for managing bovine respiratory disease complex Bovine respiratory disease complex has multiple causes. It's sometimes hard to classify and predict. It also costs the beef industry more than any other disease -- an estimated $690 million in 2006, according to one report. Chicken pox vaccination should be introduced for children in the UK The only realistic way of preventing deaths and severe complications arising from chickenpox is to routinely vaccinate children against the disease, concludes research published ahead of print in Archives of Disease in Childhood. IAVI statement on new analysis of STEP large-scale AIDS vaccine trial The International AIDS Vaccine Initiative (IAVI) issued the following statement from its President and CEO, Dr. Seth Berkley, following the release of the first analysis of the entire study population from a late-stage AIDS vaccine trial, known as the STEP study. New vaccine prevents CMV infection and disease in mice Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease. MMR, chicken pox vaccines work for preemies Vaccines for measles-mumps-rubella and varicella, or chicken pox, are effective in extremely preterm infants, even though preemies' immune systems are not as developed as full-term babies. This confirms a long-held assumption by pediatricians and neonatologists across the country. Biodegradable microspheres deliver time release vaccines, stimulate different immune response A new vaccine delivery system using microspheres of a biodegradable polymer may not only reduce the need for booster shots in some cases, but also appears to stimulate an immune response that traditional vaccines do not. Scientists find a key to immune system's ability to remember Its ability to accurately catalog and recall long past encounters with viruses, bacteria and other pathogens is why we only get the measles or chicken pox once, and is why exposure to deactivated virus particles in vaccines confers protection from disease. Analysis of Spanish flu cases in 1918-1920 suggests transfusions might help in bird flu pandemic Transfusions with blood products taken from people who had recovered from Spanish influenza may have reduced risk for death and improved symptoms of hospitalized patients who contracted Spanish influenza complicated by pneumonia. Early treatment was superior to later treatment. Innovative method for creating a human cytomegalovirus vaccine outlined Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour. More Chicken Pox Current Events and Chicken Pox News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||